Citadel Advisors’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,754
Closed -$17.5K 15696
2024
Q2
$17.5K Buy
+11,754
New +$30.8K ﹤0.01% 12748
2023
Q1
Sell
-1,136
Closed -$5.67K 15775
2022
Q4
$5.67K Sell
1,136
-3,599
-76% -$19.7K ﹤0.01% 13978
2022
Q3
$26K Sell
4,735
-12,121
-72% -$130K ﹤0.01% 11976
2022
Q2
$149K Buy
16,856
+6,715
+66% +$68.1K ﹤0.01% 10992
2022
Q1
$158K Sell
10,141
-3,137
-24% -$54.4K ﹤0.01% 11801
2021
Q4
$353K Buy
13,278
+8,878
+202% +$337K ﹤0.01% 10550
2021
Q3
$215K Buy
+4,400
New +$272K ﹤0.01% 11850
2021
Q1
Sell
-1,688
Closed -$186K 13860
2020
Q4
$170K Buy
1,688
+661
+64% +$44.1K ﹤0.01% 9858
2020
Q3
$48K Buy
+1,027
New +$52.7K ﹤0.01% 9615

Other funds holding AWH

Citadel Advisors's AWH Position: Q3 2024 in Review

Citadel Advisors sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q3 2024, closing a stake of 11,754 shares — an estimated $17.5K sold.

Citadel Advisors first reported a position in AWH in Q3 2020 and held it in 9 quarters. The position peaked at $353K in Q4 2021. 25 funds tracked by Wall St. Rank hold AWH as of Q3 2024.

  • Citadel Advisors reported no remaining Aspira Women's Health Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 11,754 Aspira Women's Health Inc. Common Stock shares in Q3 2024, an estimated $17.5K.
  • Citadel Advisors first reported a position in Aspira Women's Health Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • Citadel Advisors's Aspira Women's Health Inc. Common Stock position peaked at $353K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.